About Index Trending news
Analyze
Top 50 Pricing
Aduro BioTech

Aduro BioTech

Work at Aduro BioTech? Add yourself to this profile

Aduro BioTech

Aduro BioTech is a development-stage biopharmaceutical company engaged in the development of early-stage cancer therapies.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series D)
$51,400,000
Venture capital (Series C)
$55,000,000
Employees

Unknown size

Locations
HQ
The Motley Fool

Why a Mid-Stage Trial Is Causing Aduro Biotech to Tumble 22% Today

Xconomy

Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound

The Motley Fool

Why Aduro Biotech Is Crashing Today --